The present invention is directed to compounds represented by Formula I and pharmaceutically acceptable salts, solvates, hydrates, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to and intermediates used in making such compounds, pharmaceutical compositions containing such compounds, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.
本发明涉及由I式表示的化合物及其药学上可接受的盐、溶剂、
水合物和前药,这些化合物是Xa因子的
抑制剂。本发明还涉及用于制备这些化合物的中间体,含有这些化合物的药物组合物,预防或治疗由不良血栓形成引起的多种情况的方法,以及抑制血样的凝血方法。